Search
Search
Joseph Allen, OD, FAAO, Dipl ABO
Show Description +
The FDA recently approved acoltremon ophthalmic solution 0.003% (Tryptyr, Alcon) for the treatment of the signs and symptoms of dry eye disease. But what is Tryptyr, how does it work, and what changes can providers expect to see on the corneal surface in patients using this new drop? Joseph J. Allen, OD, FAAO, Dipl ABO, answers these questions and more in this month's episode of Eye Care Insiders.
Posted: 6/23/2025
Joseph Allen, OD, FAAO, Dipl ABO
The FDA recently approved acoltremon ophthalmic solution 0.003% (Tryptyr, Alcon) for the treatment of the signs and symptoms of dry eye disease. But what is Tryptyr, how does it work, and what changes can providers expect to see on the corneal surface in patients using this new drop? Joseph J. Allen, OD, FAAO, Dipl ABO, answers these questions and more in this month's episode of Eye Care Insiders.
Posted: 6/23/2025
_1701789080.png?auto=compress,format&w=180)
.mp4.00_05_41_04.Still001_1680887186.jpg?auto=compress,format&w=180)
.00_13_09_19.Still001_1676069079.jpg?auto=compress,format&w=180)
Please log in to leave a comment.